Cardio-Hepatic Syndrome in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair
European Journal of Heart Failure · 2023
DOI: 10.1002/ejhf.2842 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, 2023. Verfasst von Lukas Stolz und 23 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Surgical Procedures, Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
The impact of the cardio-hepatic syndrome (CHS) on outcomes in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for relevant mitral regurgitation (MR) is unknown. The objectives of this study were three-fold: (i) to characterize the pattern of hepatic impairment, (ii) to investigate the prognostic value of CHS, and (iii) to evaluate the changes in hepatic function after M-TEER. Methods and results Hepatic impairment was quantified by laboratory parameters of liver function. In accordance with existing literature, two types of CHS were distinguished: ischaemic type I CHS (elevation of both transaminases) and cholestatic type II CHS (elevation of two out of three parameters of hepatic cholestasis). The impact of CHS on 2-year mortality was evaluated using a Cox model. The change in hepatic function after M-TEER was assessed by laboratory testing at follow-up. We analysed 1083 patients who underwent M-TEER for relevant primary or secondary MR at four European centres between 2008 and 2019. Ischaemic type I and cholestatic type II CHS were observed in 11.1% and 23.0% of patients, respectively. Predictors for 2-year all-cause mortality differed by MR aetiology. While in primary MR cholestatic type II CHS was independently associated with 2-year mortality, ischaemic CHS type I was an independent mortality predictor in secondary MR patients. At follow-up, patients with MR reduction ≤2+ (obtained in 90.7% of patients) presented with improved parameters of hepatic function (median reduction of 0.2 mg/dl, 0.2 U/L and 21 U/L for bilirubin, alanine aminotransferase and gamma-glutamyl transferase, respectively, p < 0.01).
Conclusions
The CHS is frequently observed in patients undergoing M-TEER and significantly impairs 2-year survival. Successful M-TEER may have beneficial effects on CHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
- Paris University, PARCC, INSERM, European Hospital Georges Pompidou, Paris, France.
- Universitäres Herz- und Gefäßzentrum Hamburg, Klinik für Kardiologie, Hamburg, Germany.
- Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
- Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, Munich, Germany.
Zitieren
APA
Stolz, L., Orban, M., Karam, N., Lubos, E., Wild, M., Weckbach, L., Stocker, T. J., Praz, F., Braun, D., Löw, K., Hausleiter, S., Stark, K., Doldi, P., Tence, N., Orban, M., Higuchi, S., Haum, M., Windecker, S., Hagl, C., …, & Hausleiter, J. (2023). Cardio-Hepatic Syndrome in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2842
Vancouver
Stolz L, Orban M, Karam N, Lubos E, Wild M, Weckbach L, et al. Cardio-Hepatic Syndrome in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair. European Journal of Heart Failure. 2023. doi:10.1002/ejhf.2842
BibTeX
@article{Stolz2023,
author = {Stolz, Lukas and Orban, Mathias and Karam, Nicole and Lubos, Edith and Wild, Mirjam and Weckbach, Ludwig and Stocker, Thomas J and Praz, Fabien and Braun, Daniel and Löw, Kornelia and Hausleiter, Sebastian and Stark, Konstantin and Doldi, Philipp and Tence, Noemie and Orban, Martin and Higuchi, Satoshi and Haum, Magda and Windecker, Stephan and Hagl, Christian and Mayerle, Julia and Näbauer, Michael and Kalbacher, Daniel and Massberg, Steffen and Hausleiter, Jörg},
title = {Cardio-Hepatic Syndrome in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair},
journal = {European Journal of Heart Failure},
year = {2023},
doi = {10.1002/ejhf.2842}
}
EUVIMED